New approach aims to make risky bone marrow transplants safer
NCT ID NCT04395222
Summary
This study is testing whether a medication called tocilizumab can help improve bone marrow transplants for people with blood cancers. Researchers want to see if using tocilizumab instead of another standard drug can help the transplant work better while reducing serious complications. The study involves 21 adult patients who need a transplant but don't have a perfectly matched donor.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Weill Cornell Medical College
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.